HRT Use Among Women Tested for BRCA1/2 Mutations Following Publication of the Women's Health Initiative Study Results

Journal of Obstetrics and Gynaecology Canada

Volumn 27, Issue 4, 2005, Pages 321-

  Vallée, Marie Hélène ^a   Rouleau, Isabelle ^b   Chiquette, Jocelyne ^c   Plante, Marie ^b   Simard, Jacques ^a   Dorval, Michel ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c Centre des maladies du sein Deschênes Fabia   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE;

CANCER RISK; DRUG USE; DRUG WITHDRAWAL; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HEALTH BEHAVIOR; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; HETEROZYGOSITY; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; INTERPERSONAL COMMUNICATION; LETTER; MENOPAUSAL SYNDROME; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT DECISION MAKING; PATIENT EDUCATION; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SOCIAL PSYCHOLOGY; TUMOR SUPPRESSOR GENE; WOMEN'S HEALTH; ATTITUDE TO HEALTH; BREAST TUMOR; ESTROGEN THERAPY; GENETICS; MIDDLE AGED; MUTATION; NOTE; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT;

ATTITUDE TO HEALTH; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; MUTATION; RISK ASSESSMENT; WOMEN'S HEALTH;

EID: 24344460515     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30455-8     Document Type: Letter

References (3)

1. Sawka AM, Huh A, Dolovich L, Papaionannou A, Eva K, Thabane L, et al. Attitudes of women who are currently using or recently stopped estrogen replacement therapy with or without progestins: results of the AWARE Study. J Obstet Gynaecol Can 2004, 26(11):967-973.
2. Rouleau I, Chiquette J, Plante M, Simard J, Dorval M Changes in health-related behaviours following BRCA1/2 genetic testing: the case of hormone-replacement therapy. J Obstet Gynaecol Can 2004, 26(12):1059-1066.
3. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002, 288(3):321-333. Writing Group for the Women's Health Initiative Investigators.